Thus, although our findings clearly demonstrate that cerebrally produced IFN-α mediates neurotoxicity in individuals with AGS and the GIFN mouse model, a minor contribution of peripherally produced IFN-α to brain disease cannot be excluded. This evidence concerns the gene IFNA17 and Aicardi-Goutieres syndrome.